Thyroid Examination and Patient Management for NAC OSCE Canada
Direct Answer
For the NAC OSCE thyroid examination station, focus your clinical assessment on identifying high-risk features requiring specialist referral: palpable nodules with concerning characteristics, symptoms of compression or thyroid dysfunction, and specific patient risk factors including age >60 years, prior radiation exposure, family history of thyroid cancer, or autoimmune disease. 1, 2
Systematic Approach to Thyroid Examination
History Taking - Key Red Flags
Target these specific elements:
- Age and sex (women >60 years have highest prevalence) 1
- Radiation exposure history (>20 mGy to head/neck) 2
- Family history of thyroid disease or thyroid cancer 1, 2
- Personal history of autoimmune disease, type 1 diabetes, or previous thyroid dysfunction 1
- Compressive symptoms: dysphagia, dyspnea, hoarseness, or stridor 3
- Hyperthyroid symptoms: palpitations, weight loss, heat intolerance, tremor 1
- Hypothyroid symptoms: fatigue, cold intolerance, weight gain, constipation 2
- Postpartum status (increased risk period) 2
Physical Examination - Structured Technique
Execute the examination systematically:
Inspection (patient seated, neck extended):
- Visible thyroid enlargement or asymmetry
- Observe during swallowing (thyroid moves with swallowing)
- Look for exophthalmos, lid lag (hyperthyroidism signs)
Palpation (stand behind patient):
Auscultation:
- Listen for thyroid bruit (suggests Graves' disease)
Additional signs:
- Reflexes (delayed relaxation in hypothyroidism)
- Tremor, tachycardia (hyperthyroidism)
- Pretibial myxedema (Graves' disease)
Patient Management Algorithm
When to Order TSH Testing
Do NOT screen asymptomatic average-risk patients - population screening is not recommended 1, 2.
DO test TSH in these specific scenarios:
- Palpable thyroid abnormality on examination 1
- Symptoms suggestive of thyroid dysfunction 1, 2
- High-risk groups: women >60 years, postpartum women, prior radiation, family history, autoimmune disease, type 1 diabetes, atrial fibrillation 1, 2
Interpreting TSH Results
TSH <0.1 mU/L (Subclinical Hyperthyroidism):
- Consider treatment if patient is >60 years OR has cardiac disease, osteoporosis risk, or hyperthyroid symptoms 1
- Younger patients with persistent TSH <0.1 mU/L: offer therapy or close follow-up based on individual risk 1
- Order thyroid scintigraphy, T4, and T3 when TSH is low 4
TSH >6.5 mU/L (Subclinical Hypothyroidism):
- Assess for symptoms and cardiovascular risk factors 1
- Particularly important in pregnant/planning pregnancy women (poor obstetric outcomes risk) 2
Normal TSH with palpable nodule:
Thyroid Nodule Management
If nodule detected on examination:
Order thyroid ultrasound with standardized risk stratification (U-score or TIRADS classification) 3, 6
U-score interpretation and action:
Refer to specialist if:
Common Pitfalls to Avoid
Critical errors in NAC OSCE context:
- Do not order "routine thyroid screening" on asymptomatic low-risk patients - this demonstrates poor understanding of evidence-based practice 1, 2
- Do not interpret TSH in acutely ill/hospitalized patients the same as outpatients (non-thyroidal illness syndrome confounds results) 7
- Do not recommend pharmacotherapy to shrink nodules - this is obsolete practice 3
- Do not miss cervical lymphadenopathy examination - lateral neck nodes are key malignancy indicator 5
- Do not forget to assess pregnancy status in women of childbearing age - hypothyroidism affects fetal development 2
Key Differences in Canadian Context
The Canadian approach emphasizes:
- High index of suspicion in perimenopausal/postmenopausal women 2
- Aggressive case-finding in high-risk groups rather than population screening 1
- Transition of low-risk differentiated thyroid cancer patients to primary care for long-term follow-up (Canadian-specific practice pattern) 8
For NAC OSCE success, demonstrate you understand that most thyroid nodules (>80%) are asymptomatic and require no treatment 3, but you must identify the minority requiring specialist referral through systematic risk stratification.